Publications by authors named "Bridget Flavin"

Claim this Profile
A
AMCP Market Insights: Navigating the rapidly changing landscape of ER+/HER2- metastatic breast cancer.
Bridget Flavin, Denise Wolff, Laura Bobolts, Gaurang Gandhi, Ryan Haumschild

J Manag Care Spec Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma.
Bridget Flavin, Denise Wolff, Laura R Bobolts, Tara Graff, Kirollos Hanna

J Manag Care Spec Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMCP Market Insights: Payer best practices for timely diagnosis and optimal management of idiopathic hypersomnia.
Bridget Flavin, Denise Wolff, Zachary Contreras, Ryan Haumschild, Diana Kimmel

J Manag Care Spec Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMCP Market Insights: Impact of the evolving understanding of multiple sclerosis and emerging treatment approaches on managed care.
Bridget Flavin, Justin Bioc, Janna Evans, Rebecca Lich, Timothy O'Shea

J Manag Care Spec Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mind over migraine: Disease burden, innovative therapies, and managed care trends in treating migraine disease.
Bridget Flavin,

J Manag Care Spec Pharm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholder insights on cost, quality, and incorporating patient voice in managed care decisions on neovascular (wet) age-related macular degeneration: Findings from the AMCP Market Insights program.
Bridget Flavin, Andrew Schimel, Zachary Contreras, Michael H Shannon, Justin Bioc

J Manag Care Spec Pharm· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis emerging market: Preparing managed care for early intervention, equitable access, and integrating the patient perspective.
Bridget Flavin

J Manag Care Spec Pharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic graft-vs-host disease: Current understanding of disease and treatment landscape.
Bridget Flavin

J Manag Care Spec Pharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States.
Bridget M Flavin, Laura E Happe, Randy C Hatton

Expert Opin Drug Saf· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring economic impact of applying daily average consumption limits.
Bridget M Flavin, Lynn M Nishida, Sean H Karbowicz, Mark E Renner, Ruth J Leonard

J Manag Care Pharm· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis